Cryoport (CYRX) Competitors

Ardelyx (NASDAQ:ARDX) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, community ranking, analyst recommendations, institutional ownership and media sentiment.

Is ARDX or CYRX more profitable?

Ardelyx has a net margin of -11.73% compared to Cryoport's net margin of -70.08%. Cryoport's return on equity of -13.35% beat Ardelyx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardelyx	-11.73%	-24.87%	-10.51%
Cryoport	-70.08%	-13.35%	-6.43%

Does the media prefer ARDX or CYRX?

In the previous week, Ardelyx had 1 more articles in the media than Cryoport. MarketBeat recorded 8 mentions for Ardelyx and 7 mentions for Cryoport. Cryoport's average media sentiment score of 0.88 beat Ardelyx's score of 0.41 indicating that Cryoport is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardelyx	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Cryoport	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in ARDX or CYRX?

58.9% of Ardelyx shares are held by institutional investors. Comparatively, 92.9% of Cryoport shares are held by institutional investors. 5.9% of Ardelyx shares are held by company insiders. Comparatively, 10.1% of Cryoport shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts recommend ARDX or CYRX?

Ardelyx currently has a consensus price target of $10.61, suggesting a potential upside of 128.69%. Cryoport has a consensus price target of $11.83, suggesting a potential upside of 110.56%. Given Ardelyx's stronger consensus rating and higher possible upside, equities analysts plainly believe Ardelyx is more favorable than Cryoport.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardelyx	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00
Cryoport	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Does the MarketBeat Community prefer ARDX or CYRX?

Ardelyx received 288 more outperform votes than Cryoport when rated by MarketBeat users. Likewise, 67.46% of users gave Ardelyx an outperform vote while only 65.70% of users gave Cryoport an outperform vote.

Company	Underperform	Outperform
Ardelyx	Outperform Votes 537 67.46%	Underperform Votes 259 32.54%
Cryoport	Outperform Votes 249 65.70%	Underperform Votes 130 34.30%

Which has more risk & volatility, ARDX or CYRX?

Ardelyx has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500.

Which has higher earnings and valuation, ARDX or CYRX?

Ardelyx has higher revenue and earnings than Cryoport. Ardelyx is trading at a lower price-to-earnings ratio than Cryoport, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardelyx	$333.62M	3.32	-$39.14M	-$0.16	-29.00
Cryoport	$228.39M	1.23	-$99.59M	-$2.49	-2.26

Summary

Ardelyx beats Cryoport on 12 of the 19 factors compared between the two stocks.